PUBLISHER: Howe Sound Research | PRODUCT CODE: 2171570
PUBLISHER: Howe Sound Research | PRODUCT CODE: 2171570
Demand for genetic testing is strong, but the price paid for each test is under more pressure than at any time since the PAMA reforms. This report estimates the global genetic testing market at $28,300 million in 2026, growing 11.6% a year to $49,000 million in 2031 and adding $20,700 million of new annual spending. Oncology is the largest application and adds the most new dollars, oncology and prenatal testing together take more than half of all new spending, NGS rises from 38.5% to 46.5% of the market, and Direct-to-Consumer grows fastest. Genome sequencing grows test by test and will not become routine care for healthy people within the forecast period.
The past year brought CMS's preliminary 2027 lab rates with cuts of about 16% on average, Myriad's cut to its revenue guidance, strong volume growth at Quest and Labcorp, single-draw prenatal panels from Myriad, BillionToOne and Natera, the first additions to the US newborn screening panel under a new decision process, and tighter rules on genetic data in the US and China. The report covers 23 chapters, 71 tables and 52 figures, with forecasts by application, technology, sample type, customer and product for 14 countries and regions, and profiles of 48 companies.
Get our research team working for you by ordering this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information.